Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Autor: Angelo Pan, Sumanth Gandra, Elena Carrara, Souha S. Kanj, Karin Leder, Yang Soo Kim, Ana Cristina Gales, Christopher R. Houchens, Babacar Ndoye, Haibo Qiu, Lynn L. Silver, Jesús Rodríguez-Baño, Jasper Littman, David L. Paterson, Oliver J. Dyar, Paul Hansen, Mical Paul, Neil Woodford, Pilar Ramon-Pardo, Marie-Paule Kieny, Nalini Singh, Massinissa Si-Mehand, Wonkeung Song, Fidan O Yilmaz, Thomas Gottlieb, Jean B. Patel, Aaron O. Aboderin, Nguyen Van Kinh, Marc Mendelson, Seif Al-Abri, Manuel Guzman Blanco, Agnes Wechsler-Fördös, Waleria Hryniewicz, Vikas Manchanda, Timothy Jinks, Evelyn Wesangula, Gunnar Kahlmeter, Nicola Magrini, Otto Cars, Mike Sharland, Lawrence Kerr, Jaime Labarca, Debra A. Goff, Ursula Theuretzbacher, Francesco Robert Burkert, Gabriel Levy-Hara, Deepthi Kattula, Jan Kluytmans, Edward Cox, Jens Thomsen, Surbhi Malhotra-Kumar, Alexander W. Friedrich, Marco Cavaleri, Nordiah Awang Jalil, Maria Virginia Villegas, Roman S. Kozlov, Guy E. Thwaites, Kevin Outterson, Leonard Leibovici, Jos W. M. van der Meer, Stéphan Juergen Harbarth, Silvio Vega, Yehuda Carmeli, Dominique L Monnet, Lorenzo Moja, Heiman F. L. Wertheim, Martin Steinbakk, Giuseppe Cornaglia, Ramanan Laxminarayan, Maurizio Sanguinetti, Adrian Brink, Nur Benzonana, Sanjay Bhattacharya, Anna Zorzet, Alessia Savoldi, Céline Pulcini, Christian G. Giske, Herman Goossens, Evelina Tacconelli, M Lindsay Grayson, Sharmila Sengupta, Marc Ouellette

Publikováno v: Lancet Infectious Diseases, 18, 3, pp. 318-327
The Lancet Infectious Diseases
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2018, 18 (3), pp.318-327. ⟨10.1016/S1473-3099(17)30753-3⟩
The lancet infectious diseases
The Lancet Infectious Diseases, Vol. 18, No 3 (2018) pp. 318-327
Lancet Infectious Diseases, 18, 318-327

Summary Background The spread of antibiotic-resistant bacteria poses a substantial threat to morbidity and mortality worldwide. Due to its large public health and societal implications, multidrug-resistant tuberculosis has been long regarded by WHO a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18dd52a4205d1deff62e1257cc93dcfd
https://hdl.handle.net/2066/198275